Galectin-3 in heart failure: High levels are associated with all-cause mortality

International Journal of Cardiology

Volumn 150, Issue 3, 2011, Pages 361-364

  Ueland, Thor ^a,e   Aukrust, Pål ^a,b   Broch, Kaspar ^c   Aakhus, Svend ^c,d   Skårdal, Rita ^c   Muntendam, Pieter ^e   Gullestad, Lars ^c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e BG Medicine Inc   (United States)

Author keywords

Cardiac remodeling; Fibrosis; Inflammation

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIURETIC AGENT; GALECTIN 3; WARFARIN;

ADULT; ANGIOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE CELL; NONPARAMETRIC TEST; PARAMETRIC TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 79960555230     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.081     Document Type: Article

References (13)

1. M. Lainscak, A.P. Coletta, N. Sherwi, and J.G. Cleland Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1 Eur J Heart Fail 12 2010 193 196
2. D.J. Lok, M.P. Van Der, P.W. de la Porte, E. Lipsic, W.J. Van, and H.L. Hillege Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 2010 323 328
3. R.R. van Kimmenade, J.L. Januzzi Jr., P.T. Ellinor, U.C. Sharma, J.A. Bakker, and A.F. Low Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224 (Pubitemid 44345127)
4. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
5. M.A. Quinones, C.M. Otto, M. Stoddard, A. Waggoner, and W.A. Zoghbi Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 2002 167 184
6. M.D. Cerqueira, N.J. Weissman, V. Dilsizian, A.K. Jacobs, S. Kaul, and W.K. Laskey Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542 (Pubitemid 34262671)
7. J. Myers, O. Geiran, S. Simonsen, A. Ghuyoumi, and L. Gullestad Clinical and exercise test determinants of survival after cardiac transplantation Chest 124 2003 2000 2005 (Pubitemid 37433603)
8. J.O. Beitnes, O. Gjesdal, K. Lunde, S. Solheim, T. Edvardsen, and H. Arnesen Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study Eur J Echocardiogr 12 2011 98 106
9. N.C. Henderson, A.C. Mackinnon, S.L. Farnworth, T. Kipari, C. Haslett, and J.P. Iredale Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis Am J Pathol 172 2008 288 298 (Pubitemid 351282017)
10. N.C. Henderson, A.C. Mackinnon, S.L. Farnworth, F. Poirier, F.P. Russo, and J.P. Iredale Galectin-3 regulates myofibroblast activation and hepatic fibrosis Proc Natl Acad Sci U S A 103 2006 5060 5065
11. N.C. Henderson, and T. Sethi The regulation of inflammation by galectin-3 Immunol Rev 230 2009 160 171
12. R.A. de Boer, A.A. Voors, P. Muntendam, W.H. van Gilst, and D.J. van Veldhuisen Galectin-3: a novel mediator of heart failure development and progression Eur J Heart Fail 11 2009 811 817
13. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2